STOCK TITAN

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Lifeward appoints Mike Swinford, an experienced healthcare and rehabilitation technology professional, to its Board of Directors. Swinford brings over 30 years of expertise in commercialization and new business development, having served as the CEO of Numotion and in various roles at GE Healthcare. His appointment aims to strengthen Lifeward's leadership in delivering life-changing solutions for individuals with physical limitations or disabilities.
Lifeward nomina Mike Swinford, un esperto professionista nel settore della sanità e della tecnologia riabilitativa, al suo Consiglio di Amministrazione. Swinford apporta oltre 30 anni di esperienza nella commercializzazione e nello sviluppo di nuovi business, avendo ricoperto il ruolo di CEO presso Numotion e vari incarichi in GE Healthcare. Il suo incarico ha lo scopo di consolidare la leadership di Lifeward nella fornitura di soluzioni rivoluzionarie per persone con limitazioni fisiche o disabilità.
Lifeward ha designado a Mike Swinford, un experimentado profesional en tecnología de rehabilitación y atención médica, para su Junta Directiva. Swinford aporta más de 30 años de experiencia en comercialización y desarrollo de nuevos negocios, habiendo sido CEO de Numotion y ocupado varios cargos en GE Healthcare. Su nombramiento tiene como objetivo fortalecer el liderazgo de Lifeward en la entrega de soluciones transformadoras para individuos con limitaciones físicas o discapacidades.
라이프워드는 의료 및 재활 기술 분야의 경험 많은 전문가 마이크 스윈퍼드를 이사회에 임명했습니다. 스윈퍼드는 상업화 및 신규 사업 개발 분야에서 30년 이상의 전문성을 가지고 있으며, 뉴모션의 CEO로 재직하였고 GE 헬스케어에서 다양한 역할을 수행했습니다. 그의 임명은 신체적 제한이나 장애가 있는 개인들에게 변화를 가져다 줄 수 있는 해결책을 제공하는 라이프워드의 리더십을 강화하기 위한 것입니다.
Lifeward nomme Mike Swinford, un professionnel expérimenté de la santé et de la technologie de réadaptation, à son Conseil d'Administration. Swinford apporte plus de 30 ans de compétences en commercialisation et développement de nouveaux business, ayant servi en tant que PDG de Numotion et dans divers rôles chez GE Healthcare. Sa nomination vise à renforcer le leadership de Lifeward dans la fourniture de solutions révolutionnaires pour les personnes ayant des limitations physiques ou des handicaps.
Lifeward ernennt Mike Swinford, einen erfahrenen Fachmann im Bereich Gesundheitswesen und Reha-Technologie, zu seinem Vorstand. Swinford bringt mehr als 30 Jahre Erfahrung in der Kommerzialisierung und der Entwicklung neuer Geschäftsfelder mit, da er als CEO von Numotion und in verschiedenen Positionen bei GE Healthcare tätig war. Seine Ernennung zielt darauf ab, die Führungsrolle von Lifeward bei der Bereitstellung lebensverändernder Lösungen für Menschen mit körperlichen Einschränkungen oder Behinderungen zu stärken.
Positive
  • None.
Negative
  • None.

Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 19, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market lead delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, announced that the Board has approved the appointment of Mike Swinford to the Board of Directors, effective April 18, 2024.

Mr. Swinford has been Chief Executive Officer of Numotion since July 2014, where he has grown the company to become the largest provider of mobility and independence solutions in the United States - serving over 400,000 individuals annually with Spinal Cord Injuries, Traumatic Brain Injuries, ALS, Muscular Dystrophy, Cerebral Palsy, Multiple Sclerosis, Spinal Muscular Atrophy, Amputees and many other mobility related disabilities. As CEO at Numotion, he has expanded commercial coverage with over 5000 health plans, rehab hospitals, specialty and multi-disciplinary clinics, skilled nursing facilities, primary care, and home health providers. He has led efforts for benefit coverage determination for Power Wheelchair Seat Elevation systems in 2023 and is actively leading efforts for Power Standing Wheelchairs and reform of Service and Repair regulations and reimbursement levels.

Prior to Numotion, he had a highly successful 22-year career at GE Healthcare, including serving as the President and CEO of GE Healthcare Services and as an officer of General Electric Company. Mr. Swinford held various operational and commercial roles throughout his career leading through various business cycles from start-ups to turnarounds. Mr. Swinford also serves as a director of CareATC, a technology enabled population health primary care provider, as well as a director of Aspen Surgical, a global surgical supply manufacturer. 

“As someone who is passionate about improving healthcare access and inclusion for people with disabilities, I am excited to join the Board of Directors of Lifeward,” said Mr. Swinford. “I look forward to bringing my knowledge of the industry and my experience with CMS coverage implementation to help Lifeward further its commercialization strategies for the benefit of the disabled community.”

“Mike Swinford brings unique experience and familiarity with the industry and reimbursement to our Board,” said Jeff Dykan, Chairman of the Board of Directors of Lifeward. “He has a remarkable track record that is an excellent fit with our focus on commercialization and expanded access to devices for physical rehabilitation and recovery, and his commitment to furthering opportunities for people with disabilities is an inspiration to us all. This is another step to increase the direct commercialization skills and experience within our Board. We are delighted to welcome Mike to the Board.”

For more information, please visit GoLifeward.com

About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES Systems.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit GoLifeward.com.

ReWalk®, ReStore® and Alter G® are registered trademarks of ReWalk Robotics Ltd. (DBA Lifeward) and/or its affiliates.

Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding the Company’s future performance and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek," and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in the Company’s periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading "Risk Factors" in the Company’s annual report on Form 10-K for the year ended December 31, 2023 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Lifeward Media Relations:
LifeSci Communications
E: media@golifeward.com

Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com

 


FAQ

Who has Lifeward appointed to its Board of Directors?

Lifeward has appointed Mike Swinford to its Board of Directors.

What is Mike Swinford's background?

Mike Swinford is an experienced healthcare and rehabilitation technology professional with over 30 years of experience in commercialization and new business development.

What is Numotion and Mike Swinford's role there?

Numotion is the largest provider of mobility and independence solutions in the United States, serving individuals with various mobility-related disabilities. Mike Swinford has been the CEO of Numotion since July 2014.

What is Mike Swinford's connection to GE Healthcare?

Mike Swinford had a successful 22-year career at GE Healthcare, including serving as the President and CEO of GE Healthcare Services.

What other companies does Mike Swinford serve as a director for?

Mike Swinford serves as a director of CareATC, a technology-enabled primary care provider, and Aspen Surgical, a global surgical supply manufacturer.

Lifeward Ltd. Ordinary Shares

NASDAQ:LFWD

LFWD Rankings

LFWD Latest News

LFWD Stock Data

13.21M
8.52M
2.77%
21.64%
1.53%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
MARLBOROUGH